Jiangsu-based Contract Development and Manufacturing Organization (CDMO) Sinopep-Allsino Biopharmaceutical Co., Ltd (SHA: 688076) has announced a strategic partnership with US-based Spraying Systems Co. to collaborate on the application of electrostatic spray drying technology in the commercial manufacturing of peptide active pharmaceutical ingredients (APIs).
Enhancing Market Advantages in Peptide Manufacturing
The collaboration, financial details of which were not disclosed, is anticipated to strengthen the market position of both companies within the peptide manufacturing sector. The partnership aims to boost production capabilities to tens of tons or more per year, highlighting the scale of the ambition and the potential impact on the industry.
PolarDry Technology to Boost Production Efficiency
The introduction of PolarDry electrostatic spray drying equipment is expected to significantly enhance production efficiency and reduce costs in the manufacturing process. This technological advancement will be a key driver in achieving the production targets set by the partnership.
Delivery of Equipment Scheduled for 2027
The delivery of 16 units of the advanced equipment is planned to be completed by the end of 2027. This timeline underscores the commitment of both Sinopep-Allsino Biopharmaceutical Co., Ltd and Spraying Systems Co. to invest in state-of-the-art technology for the peptide API market.-Fineline Info & Tech
